409 related articles for article (PubMed ID: 18063667)
1. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
[TBL] [Abstract][Full Text] [Related]
2. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus.
Kozyrev SV; Lewén S; Reddy PM; Pons-Estel B; ; Witte T; ; Junker P; Laustrup H; Gutiérrez C; Suárez A; Francisca González-Escribano M; Martín J; ; Alarcón-Riquelme ME
Arthritis Rheum; 2007 Apr; 56(4):1234-41. PubMed ID: 17393452
[TBL] [Abstract][Full Text] [Related]
3. An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases.
Dideberg V; Kristjansdottir G; Milani L; Libioulle C; Sigurdsson S; Louis E; Wiman AC; Vermeire S; Rutgeerts P; Belaiche J; Franchimont D; Van Gossum A; Bours V; Syvänen AC
Hum Mol Genet; 2007 Dec; 16(24):3008-16. PubMed ID: 17881657
[TBL] [Abstract][Full Text] [Related]
4. The CGGGG insertion/deletion polymorphism of the IRF5 promoter is a strong risk factor for primary Sjögren's syndrome.
Miceli-Richard C; Gestermann N; Ittah M; Comets E; Loiseau P; Puechal X; Hachulla E; Gottenberg JE; Lebon P; Becquemont L; Mariette X
Arthritis Rheum; 2009 Jul; 60(7):1991-7. PubMed ID: 19565491
[TBL] [Abstract][Full Text] [Related]
5. Opposed independent effects and epistasis in the complex association of IRF5 to SLE.
Ferreiro-Neira I; Calaza M; Alonso-Perez E; Marchini M; Scorza R; Sebastiani GD; Blanco FJ; Rego I; Pullmann R; Pullmann R; Kallenberg CG; Bijl M; Skopouli FN; Mavromati M; Migliaresi S; Barizzone N; Ruzickova S; Dostal C; Schmidt RE; Witte T; Papasteriades C; Kappou-Rigatou I; Endreffy E; Kovacs A; Ordi-Ros J; Balada E; Carreira P; Gomez-Reino JJ; Gonzalez A
Genes Immun; 2007 Jul; 8(5):429-38. PubMed ID: 17568788
[TBL] [Abstract][Full Text] [Related]
6. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
Graham RR; Kozyrev SV; Baechler EC; Reddy MV; Plenge RM; Bauer JW; Ortmann WA; Koeuth T; González Escribano MF; ; Pons-Estel B; Petri M; Daly M; Gregersen PK; Martín J; Altshuler D; Behrens TW; Alarcón-Riquelme ME
Nat Genet; 2006 May; 38(5):550-5. PubMed ID: 16642019
[TBL] [Abstract][Full Text] [Related]
7. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
[TBL] [Abstract][Full Text] [Related]
8. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
[TBL] [Abstract][Full Text] [Related]
9. Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts.
Nordang GB; Viken MK; Amundsen SS; Sanchez ES; Flatø B; Førre OT; Martin J; Kvien TK; Lie BA
Rheumatology (Oxford); 2012 Apr; 51(4):619-26. PubMed ID: 22179739
[TBL] [Abstract][Full Text] [Related]
10. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus.
Hu W; Ren H
Int J Immunogenet; 2011 Oct; 38(5):411-7. PubMed ID: 21834935
[TBL] [Abstract][Full Text] [Related]
12. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis.
Rueda B; Reddy MV; González-Gay MA; Balsa A; Pascual-Salcedo D; Petersson IF; Eimon A; Paira S; Scherbarth HR; Pons-Estel BA; González-Escribano MF; Alarcón-Riquelme ME; Martín J
Arthritis Rheum; 2006 Dec; 54(12):3815-9. PubMed ID: 17133578
[TBL] [Abstract][Full Text] [Related]
13. Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis.
Dieguez-Gonzalez R; Calaza M; Perez-Pampin E; de la Serna AR; Fernandez-Gutierrez B; Castañeda S; Largo R; Joven B; Narvaez J; Navarro F; Marenco JL; Vicario JL; Blanco FJ; Fernandez-Lopez JC; Caliz R; Collado-Escobar MD; Carreño L; Lopez-Longo J; Cañete JD; Gomez-Reino JJ; Gonzalez A
Arthritis Rheum; 2008 May; 58(5):1264-74. PubMed ID: 18438842
[TBL] [Abstract][Full Text] [Related]
14. A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.
Kim K; Cho SK; Han TU; Kim JH; Kang SJ; Kang C; Bae SC
Lupus; 2013 Nov; 22(13):1336-40. PubMed ID: 24014567
[TBL] [Abstract][Full Text] [Related]
15. Variants of the interferon regulatory factor 5 gene regulate expression of IRF5 mRNA in atherosclerotic tissue but are not associated with myocardial infarction.
Mälarstig A; Sigurdsson S; Eriksson P; Paulsson-Berne G; Hedin U; Wallentin L; Siegbahn A; Hamsten A; Syvänen AC
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):975-82. PubMed ID: 18323517
[TBL] [Abstract][Full Text] [Related]
16. The genetics and biology of Irf5-mediated signaling in lupus.
Kozyrev SV; Alarcon-Riquelme ME
Autoimmunity; 2007 Dec; 40(8):591-601. PubMed ID: 18075793
[TBL] [Abstract][Full Text] [Related]
17. Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus.
Myouzen K; Kochi Y; Shimane K; Fujio K; Okamura T; Okada Y; Suzuki A; Atsumi T; Ito S; Takada K; Mimori A; Ikegawa S; Yamada R; Nakamura Y; Yamamoto K
Hum Mol Genet; 2010 Jun; 19(11):2313-20. PubMed ID: 20194224
[TBL] [Abstract][Full Text] [Related]
18. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
19. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome.
Yin H; Borghi MO; Delgado-Vega AM; Tincani A; Meroni PL; Alarcón-Riquelme ME
Arthritis Rheum; 2009 Aug; 60(8):2468-71. PubMed ID: 19644876
[TBL] [Abstract][Full Text] [Related]
20. Promoter insertion/deletion in the IRF5 gene is highly associated with susceptibility to systemic lupus erythematosus in distinct populations, but exerts a modest effect on gene expression in peripheral blood mononuclear cells.
Löfgren SE; Yin H; Delgado-Vega AM; Sanchez E; Lewén S; Pons-Estel BA; Witte T; D'Alfonso S; Ortego-Centeno N; Martin J; Alarcón-Riquelme ME; Kozyrev SV
J Rheumatol; 2010 Mar; 37(3):574-8. PubMed ID: 20080916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
